Pediatrix shareholders approve 8M share increase in incentive plan; director Starcher faces 36% withhold vote

Pediatrix Medical Group, Inc.

Shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan, increasing authorized shares by 8,000,000.
Director John M. Starcher, Jr. received 46,296,745 votes for (55%) and 25,909,618 against (36% of votes cast excluding broker non-votes).
PricewaterhouseCoopers LLP ratified as auditor for 2026 with 75,519,473 for (97.6% of votes cast).
Advisory vote on named executive officer compensation for 2025 approved with 70,257,832 for (97.3% of votes cast excluding broker non-votes).
All other director nominees received over 98% support from votes cast.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.